Barclays Maintains Overweight on Cognex, Raises Price Target to $64

Benzinga Newsdesk www.benzinga.com Positive 81.3%

Neg 0% Neu 0% Pos 81.3%

Barclays analyst Guy Hardwick maintains Cognex (NASDAQ:CGNX) with a Overweight and raises the price target from $61 to $64.